Autoimmune Diseases

Latest News

Methotrexate, Leflunomide Linked to Higher Risk of Adverse Pregnancy Outcomes in Patients With RA
Methotrexate, Leflunomide Linked to Higher Risk of Adverse Pregnancy Outcomes in Patients With RA

April 8th 2024

Due to the increased possibility of adverse pregnancy outcomes associated with methotrexate and leflunomid, it is crucial that patients with rheumatoid arthritis (RA) engage in thorough consultations with their physicians regarding pregnancy planning.

Tocilizumab-aazg Is First IV, Subcutaneous Tocilizumab Biosimilar With FDA Approval
Tocilizumab-aazg Is First IV, Subcutaneous Tocilizumab Biosimilar With FDA Approval

March 7th 2024

FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After Approval
FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After Approval

February 26th 2024

COVID-19 Vaccine Shows Reduced Effect in Patients With RA Receiving DMARDs
COVID-19 Vaccine Shows Reduced Effect in Patients With RA Receiving DMARDs

January 2nd 2024

Slideshow: 2023 Biosimilar Approvals
Slideshow: 2023 Biosimilar Approvals

December 25th 2023

Latest CME Events & Activities

Turning Food Allergy Triggers Into Therapy: A Managed Care Lens on Immunotherapy and Targeted Biologics

1.5 Credits / Immunology

View More

Individualizing Care for Patients With PIDD: The Role of the Pharmacist in Managing Patients on IVIg and SCIg

1.5 Credits / Immunology

View More

Understanding the Role of IVIg and SCIg for the Management of CIDP: Information the Pharmacist Needs to Know to Optimize Care, featuring a Patient Perspective

1.5 Credits / Immunology, Neurology

View More

Targeted Therapies for the Management of Eosinophilic Esophagitis Across the Life Cycle: The Role of the Pharmacist in Patient Identification and Optimization, featuring a Pat...

1.5 Credits / Immunology

View More

Discerning the Significant Burden of Prurigo Nodularis: The Role of Targeted Therapies in Improving Patient Quality of Life, featuring a Patient Perspective

1.5 Credits / Dermatology, Immunology

View More

Reducing the Clinical and Economic Burden of Managing CRSwNP With Emerging Targeted Therapies: A Review for Specialty Pharmacists, featuring a Patient Perspective

1.5 Credits / Immunology

View More

Reducing the Clinical and Caregiver Burden of Moderate to Severe Pediatric Atopic Dermatitis Through Improved Access to Treatments, featuring a Caregiver Perspective

1.5 Credits / Dermatology, Immunology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Exploring Targeted Treatment Options for Hereditary Angioedema: Considerations for Pharmacists

1.0 Credit / Immunology

View More

Unveiling the Impact of Childhood Eczema: A Guide to Moderate-Severe Pediatric Atopic Dermatitis

1.0 Credit / Dermatology, Immunology

View More

Revolutionizing Pediatric Atopic Dermatitis Treatment With Targeted Biologics

1.0 Credit / Dermatology, Immunology

View More

Practical Approaches in the Management of Primary Immunodeficiency Disorders: Understanding the Role of Intravenous and Subcutaneous Immunoglobulin

1.0 Credit / Immunology, Rare Diseases

View More

Maximizing the Potential of Biologics in Moderate to Severe Pediatric Atopic Dermatitis: The Expertise of the Specialty Pharmacist

1.0 Credit / Dermatology, Immunology

View More

Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment

1.5 Credits / Allergy, Immunology

View More

Best Practices for Optimizing Biologic Therapy Management for Moderate to Severe Atopic Dermatitis in Children

1.5 Credits / Dermatology, Immunology

View More

Integrating Biologic Therapy Into Clinical Practice for the Management of Eosinophilic Esophagitis

1.5 Credits / Gastroenterology, Immunology

View More

Understanding the Burden of Eosinophilic Esophagitis in Children

1.0 Credit / Gastroenterology, Immunology

View More

The Expertise of the Specialty Pharmacist in Pediatric Eosinophilic Esophagitis

1.0 Credit / Gastroenterology, Immunology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Emerging Biologic Therapy for the Management of Eosinophilic Esophagitis in Children

1.0 Credit / Gastroenterology, Immunology

View More

Optimizing Inflammatory Bowel Disease Treatment: A Pharmacist's Guide to Biologics and Monoclonal Antibodies

1.0 Credits / Gastroenterology, Immunology

View More

Navigating the Complexities of Biologic Therapy for Moderate to Severe Atopic Dermatitis in Children: The Impact of Pharmacists on Patient Care

1.5 Credit / Dermatology, Immunology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.